Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Jose-Alberto Palma, MD, PhD is a physician-scientist with over fifteen years of experience in clinical trials and drug development, dedicated to advancing medical research and patient care. From 2015 to 2020, he worked as a principal investigator of neurodegeneration clinical trials at New York University (NYU) Grossman School of Medicine. In 2020, he transitioned to the pharmaceutical industry, taking on the global clinical trial lead role for neurodegeneration programs at Novartis, and continued this work at Eli Lily from 2023 onwards.
Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.
Vendeur : Housing Works Online Bookstore, New York, NY, Etats-Unis
Etat : Very Good. Minimal wear to cover. Pages clean and binding tight. shelf wear. bumped edges. Hardcover. N° de réf. du vendeur KB3-01075
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : New. N° de réf. du vendeur 52108665-n
Quantité disponible : 4 disponible(s)
Vendeur : Rarewaves.com USA, London, LONDO, Royaume-Uni
Hardback. Etat : New. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This gap is not merely due to a lack of interest; the clinical trial process can be daunting, often leaving patients and their families uninformed, unprepared and overwhelmed. This book offers a much-needed, clear, balanced, and comprehensive guidance at a moment when patient-centered care has never been more important. It demystifies how trials work, what patients can expect, and how to weigh the promise of cutting-edge treatments against the challenges and potential risks involved. It simultaneously empowers patients and caregivers to make informed decisions, turning a process that can feel intimidating into one that is understandable, navigable, and ultimately hopeful. N° de réf. du vendeur LU-9798881842475
Quantité disponible : Plus de 20 disponibles
Vendeur : PBShop.store US, Wood Dale, IL, Etats-Unis
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur GB-9798881842475
Quantité disponible : 4 disponible(s)
Vendeur : Brook Bookstore On Demand, Napoli, NA, Italie
Etat : new. N° de réf. du vendeur 6YIVBEVTGH
Quantité disponible : 5 disponible(s)
Vendeur : GreatBookPrices, Columbia, MD, Etats-Unis
Etat : As New. Unread book in perfect condition. N° de réf. du vendeur 52108665
Quantité disponible : 4 disponible(s)
Vendeur : PBShop.store UK, Fairford, GLOS, Royaume-Uni
HRD. Etat : New. New Book. Shipped from UK. Established seller since 2000. N° de réf. du vendeur GB-9798881842475
Quantité disponible : 4 disponible(s)
Vendeur : Rarewaves USA, OSWEGO, IL, Etats-Unis
Hardback. Etat : New. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This gap is not merely due to a lack of interest; the clinical trial process can be daunting, often leaving patients and their families uninformed, unprepared and overwhelmed. This book offers a much-needed, clear, balanced, and comprehensive guidance at a moment when patient-centered care has never been more important. It demystifies how trials work, what patients can expect, and how to weigh the promise of cutting-edge treatments against the challenges and potential risks involved. It simultaneously empowers patients and caregivers to make informed decisions, turning a process that can feel intimidating into one that is understandable, navigable, and ultimately hopeful. N° de réf. du vendeur LU-9798881842475
Quantité disponible : 2 disponible(s)
Vendeur : Grand Eagle Retail, Bensenville, IL, Etats-Unis
Hardcover. Etat : new. Hardcover. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Yet only a small fraction of patients participates in clinical trials, even though these studies are vital to developing new therapies. Fewer than 8 percent of adult cancer patients take part in these trials, with even lower rates among Black and Hispanic populations. This gap is not merely due to a lack of interest; the clinical trial process can be daunting, often leaving patients and their families uninformed, unprepared and overwhelmed. This book offers a much-needed, clear, balanced, and comprehensive guidance at a moment when patient-centered care has never been more important. It demystifies how trials work, what patients can expect, and how to weigh the promise of cutting-edge treatments against the challenges and potential risks involved. It simultaneously empowers patients and caregivers to make informed decisions, turning a process that can feel intimidating into one that is understandable, navigable, and ultimately hopeful. Every year, millions of people face life-threatening illnesses for which effective treatments are limited or nonexistent. Shipping may be from multiple locations in the US or from the UK, depending on stock availability. N° de réf. du vendeur 9798881842475
Quantité disponible : 1 disponible(s)
Vendeur : GreatBookPricesUK, Woodford Green, Royaume-Uni
Etat : New. N° de réf. du vendeur 52108665-n
Quantité disponible : 4 disponible(s)